Clinical trial
A Prospective Registry for the Evaluation of the Safety, Efficacy and Clinical Impact of the Double Hemostasis System Terry2 (TM) on Patients Undergoing a Trans-radial or Trans-cubital Catheterism.
NCT04933136 is registered in ClinicalTrials.gov with Laval University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Registry for the Evaluation of the Safety, Efficacy and Clinical Impact of the Double Hemostasis System Terry2 (TM) on Patients Undergoing a Trans-radial or Trans-cubital Catheterism.
- Lead sponsor
- Laval University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 12, 2022
- Completion date
- December 31, 2025
- Enrollment
- 500 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
radial artery occlusion